What is the recommended dosage of diltiazem (calcium channel blocker) for a 71-year-old patient with potential hypotension (low blood pressure) and impaired renal (kidney) or hepatic (liver) function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diltiazem Dosing in a 71-Year-Old Patient

Start with diltiazem 120 mg once daily using an extended-release formulation, and titrate cautiously over several weeks while closely monitoring blood pressure and heart rate, particularly given the increased risk of hypotension in elderly patients. 1, 2

Initial Dosing Strategy

  • Begin with 120 mg once daily of an extended-release formulation (such as Cardizem CD), which represents the minimum effective starting dose for elderly patients 1, 3
  • The 120 mg starting dose is specifically recommended for elderly patients (age 65-85 years) to minimize adverse effects while maintaining efficacy 2
  • Extended-release formulations provide consistent 24-hour blood pressure control and allow once-daily dosing, improving adherence 1, 4

Titration and Dose Adjustment

  • Titrate gradually at 1-2 week intervals based on blood pressure response and tolerability 1, 2
  • The therapeutic range extends from 120-360 mg daily, though elderly patients often respond optimally to lower doses 1, 3
  • For elderly patients specifically, 180-200 mg once daily is often the optimal dose, with one study demonstrating that 180 mg/day provided adequate angina control with fewer adverse effects than higher doses in patients aged 71-82 years 5
  • If blood pressure control is inadequate at 200 mg, the dose can be increased to 300 mg once daily 2
  • Maximum dose is 360 mg daily, though doses above 240 mg show incremental but modest additional benefit 6, 4

Critical Monitoring Requirements

Blood Pressure and Heart Rate:

  • Monitor blood pressure and heart rate at each dose adjustment (every 1-2 weeks initially) 1
  • Reassess patients 1 month after initiation or dose changes 1
  • Hypotension is the most common adverse effect, particularly in elderly patients, and requires careful monitoring 1, 7

Cardiac Monitoring:

  • Obtain baseline ECG and monitor for conduction abnormalities, especially if the patient has any pre-existing conduction system disease 1
  • Watch for bradycardia, which may be dose-limiting 1

Liver Function:

  • Check liver function tests if clinically indicated, as diltiazem is hepatically metabolized 1

Special Considerations for Elderly Patients

Renal and Hepatic Impairment:

  • If renal or hepatic dysfunction is present, titration must be carried out with particular caution, as no specific dosing guidelines exist for these populations 3
  • Start at the lowest dose (120 mg) and increase more slowly than in younger patients 3

Common Adverse Effects in the Elderly:

  • Constipation is particularly problematic in elderly patients and may be severe enough to require discontinuation 5
  • Peripheral edema occurs in a dose-dependent manner and is more common in women; consider adding a diuretic if this develops 1
  • Dizziness and lightheadedness from hypotension 2, 7

Absolute Contraindications

Do not use diltiazem if the patient has: 1, 3

  • Second or third-degree AV block without a functioning pacemaker
  • Sick sinus syndrome without a pacemaker
  • Decompensated systolic heart failure or severe left ventricular dysfunction
  • Cardiogenic shock
  • Wolff-Parkinson-White syndrome with atrial fibrillation/flutter
  • Hypotension (systolic BP <90 mmHg)

Drug Interactions to Avoid

  • Do not combine with beta-blockers unless absolutely necessary, as this significantly increases the risk of bradycardia, heart block, and heart failure 1
  • Exercise caution with other CYP3A4 substrates and inhibitors (diltiazem is both a CYP3A4 substrate and moderate inhibitor), including cyclosporine, simvastatin, and certain anticoagulants 1
  • Avoid concurrent use with medications that affect SA/AV nodal conduction 1

Practical Dosing Algorithm

  1. Start: 120 mg once daily (extended-release formulation) 1, 2
  2. Week 2-4: Assess response - if blood pressure not at goal and no adverse effects, increase to 180-200 mg once daily 2, 5
  3. Week 6-8: Reassess - if still inadequate control, increase to 240-300 mg once daily 2, 6
  4. Maximum: 360 mg once daily if needed, though elderly patients rarely require this dose 1, 3

Common Pitfalls to Avoid

  • Do not split, crush, or attempt to "half" extended-release formulations - they must be swallowed whole to maintain their controlled-release properties 1
  • Do not use immediate-release formulations once daily - these require 3-4 times daily dosing 3
  • Do not escalate doses too rapidly in elderly patients - this increases the risk of hypotension and other adverse effects 1, 5
  • Do not assume diltiazem requires tapering when discontinuing - unlike beta-blockers, there is no significant withdrawal syndrome, and the medication can be stopped abruptly if needed 8

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.